HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoqing Tan Selected Research

Therapeutics

1/2022Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoqing Tan Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 03/2009
2Vascular Calcification
09/2022 - 11/2021
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 11/2020
2Glioma (Gliomas)
02/2011 - 03/2009
1Carotid Artery Diseases
02/2024
1Atherosclerotic Plaque (Atheroma)
02/2024
1Atherosclerosis
10/2023
1Prediabetic State (Prediabetes)
10/2023
1Hyperglycemia
10/2023
1Inflammation (Inflammations)
01/2023
1Type 2 Diabetes Mellitus (MODY)
12/2022
1Gestational Diabetes (Gestational Diabetes Mellitus)
03/2022
1Insulin Resistance
03/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
11/2021
1Heart Failure
11/2021
1Hypertension (High Blood Pressure)
11/2021
1Sclerosing Cholangitis
01/2021
1Eosinophilia
11/2020
1Endometrial Neoplasms (Endometrial Cancer)
01/2019
1Pneumonia (Pneumonitis)
03/2015
1Chronic Urticaria
07/2014
1Melanoma (Melanoma, Malignant)
02/2013
1Glioblastoma (Glioblastoma Multiforme)
02/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2011
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
02/2011

Drug/Important Bio-Agent (IBA)

2Glucose (Dextrose)FDA LinkGeneric
12/2022 - 03/2022
2Messenger RNA (mRNA)IBA
09/2022 - 07/2014
2Proteins (Proteins, Gene)FDA Link
09/2022 - 07/2014
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2011 - 03/2009
2Imatinib Mesylate (Gleevec)FDA Link
02/2011 - 03/2009
1HomocysteineIBA
02/2024
1C-Reactive ProteinIBA
10/2023
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10/2023
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2023
1Blood Glucose (Blood Sugar)IBA
12/2022
1UrocortinsIBA
09/2022
1CateninsIBA
09/2022
1Beclin-1IBA
09/2022
1Insulin (Novolin)FDA Link
03/2022
1MagnesiumIBA
03/2022
1MetallothioneinIBA
01/2022
1Alkaline PhosphataseIBA
11/2021
1AldosteroneIBA
11/2021
1urotensin IIIBA
11/2021
1CalciumIBA
11/2021
1Hormones (Hormone)IBA
11/2021
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
11/2021
1OsteopontinIBA
11/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
11/2020
1PhosphoproteinsIBA
01/2019
1FMN ReductaseIBA
03/2015
1Toll-Like Receptor 2IBA
07/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2014
1DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA
07/2014
1Interleukin-2 (IL2)IBA
02/2013
1MitogensIBA
02/2013
1Tyrosine Kinase InhibitorsIBA
02/2011
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
02/2011
1Small Interfering RNA (siRNA)IBA
02/2011
1Phosphotransferases (Kinase)IBA
03/2009
1Tyrosine (L-Tyrosine)FDA Link
03/2009
1Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2009
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
03/2009

Therapy/Procedure

1Glycemic Control
03/2022
1Therapeutics
01/2022
1Subcutaneous Injections
02/2013